Total Payments
$6,206
2024 Payments
$938.95
Companies
36
Transactions
273
Medicare Patients
1,517
Medicare Billing
$287,259
Payment Breakdown by Category
Food & Beverage$4,639 (74.8%)
Travel$1,567 (25.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,639 | 263 | 74.8% |
| Travel and Lodging | $1,567 | 6 | 25.2% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
General
$6,206
269 transactions
Ownership
$0
4 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $2,214 | 20 | $0 (2024) |
| ABBVIE INC. | $1,010 | 65 | $0 (2024) |
| Janssen Biotech, Inc. | $596.78 | 39 | $0 (2024) |
| Celgene Corporation | $488.99 | 34 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $389.46 | 23 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $290.17 | 17 | $0 (2024) |
| Ardelyx, Inc. | $186.83 | 10 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $101.42 | 7 | $0 (2022) |
| GENZYME CORPORATION | $96.80 | 5 | $0 (2024) |
| Daiichi Sankyo Inc. | $54.40 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $938.95 | 62 | ABBVIE INC. ($188.82) |
| 2023 | $807.11 | 50 | Celgene Corporation ($199.97) |
| 2022 | $673.78 | 48 | Celgene Corporation ($216.79) |
| 2021 | $423.21 | 28 | Janssen Biotech, Inc. ($132.84) |
| 2020 | $446.76 | 26 | Boston Scientific Corporation ($139.75) |
| 2019 | $582.11 | 13 | Boston Scientific Corporation ($475.33) |
| 2018 | $1,834 | 22 | BOSTON SCIENTIFIC CORPORATION ($1,526) |
| 2017 | $499.60 | 24 | AbbVie, Inc. ($271.02) |
All Payment Transactions
273 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.65 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Immunology | ||||||
| 12/11/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: LIVER DISEASE | ||||||
| 12/10/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.10 | General |
| Category: Immunology | ||||||
| 11/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $6.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/27/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $0.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $4.16 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Gastroenterology | ||||||
| 10/31/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: LIVER DISEASE | ||||||
| 10/24/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $17.18 | General |
| Category: IMMUNOLOGY | ||||||
| 10/22/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: INTERNAL MEDICINE | ||||||
| 10/14/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.19 | General |
| Category: Neuroscience | ||||||
| 10/01/2024 | PFIZER INC. | XELJANZ (Drug), VELSIPITY | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 09/25/2024 | Celltrion USA Inc. | VEGZELMA (Biological) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: ONCOLOGY | ||||||
| 09/24/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Immunology | ||||||
| 09/23/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $7.24 | General |
| Category: IMMUNOLOGY | ||||||
| 09/03/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ENTYVIO (Biological) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/29/2024 | Janssen Biotech, Inc. | STELARA (Biological) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Immunology | ||||||
| 08/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Immunology | ||||||
| 08/20/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $15.53 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: IMMUNOLOGY | ||||||
| 08/14/2024 | ABBVIE INC. | RINVOQ (Biological), SKYRIZI | Food and Beverage | In-kind items and services | $1.78 | General |
| Category: IMMUNOLOGY | ||||||
| 08/13/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: GASTROENTEROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 423 | 7,309 | $645,696 | $156,434 |
| 2022 | 11 | 341 | 646 | $181,329 | $44,359 |
| 2021 | 11 | 344 | 395 | $162,152 | $41,377 |
| 2020 | 14 | 409 | 2,122 | $190,953 | $45,089 |
Total Patients
1,517
Total Services
10,472
Medicare Billing
$287,259
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J3380 | Injection, vedolizumab, 1 mg | Office | 2023 | 14 | 6,600 | $448,800 | $109,401 | 24.4% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 183 | $27,816 | $6,369 | 22.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2023 | 29 | 30 | $31,946 | $5,918 | 18.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 43 | 56 | $12,152 | $5,105 | 42.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 23 | 102 | $10,200 | $4,703 | 46.1% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 48 | 48 | $13,974 | $4,623 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 69 | $10,212 | $4,018 | 39.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 35 | 55 | $8,582 | $3,239 | 37.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 25 | 25 | $8,300 | $2,873 | 34.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 25 | 25 | $5,475 | $1,885 | 34.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 35 | 35 | $24,515 | $1,872 | 7.6% |
| 43248 | Insertion of guide wire with dilation of esophagus using a flexible endoscope | Facility | 2023 | 18 | 18 | $12,821 | $1,805 | 14.1% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 22 | 22 | $12,299 | $1,790 | 14.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $15,246 | $1,787 | 11.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 15 | 23 | $3,358 | $1,045 | 31.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 107 | $23,219 | $8,777 | 37.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 17 | 176 | $26,752 | $5,931 | 22.2% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Facility | 2022 | 28 | 28 | $29,693 | $5,173 | 17.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 47 | 47 | $15,604 | $5,083 | 32.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 47 | 48 | $13,962 | $4,748 | 34.0% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 17 | 97 | $9,700 | $4,282 | 44.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 47 | $7,184 | $2,537 | 35.3% |
| 43264 | Removal of stone or debris from bile or pancreatic duct using a flexible endoscope | Facility | 2022 | 12 | 15 | $19,440 | $2,428 | 12.5% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 33 | 34 | $23,140 | $2,209 | 9.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 28 | 33 | $4,884 | $1,986 | 40.7% |
About Mark Porta
Mark Porta is a Internal Medicine healthcare provider based in Shreveport, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/12/2012. The National Provider Identifier (NPI) number assigned to this provider is 1275890436.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Mark Porta has received a total of $6,206 in payments from pharmaceutical and medical device companies, with $938.95 received in 2024. These payments were reported across 273 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($4,639).
As a Medicare-enrolled provider, Porta has provided services to 1,517 Medicare beneficiaries, totaling 10,472 services with total Medicare billing of $287,259. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Shreveport, LA
- Active Since 04/12/2012
- Last Updated 07/30/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1275890436
Products in Payments
- SPYGLASS (Device) $962.65
- GENERAL THERAPIES (Device) $625.36
- STELARA (Biological) $510.09
- ZEPOSIA (Drug) $447.77
- GENERAL BILIARY DEVICES (Device) $389.66
- Humira (Biological) $302.98
- XIFAXAN (Drug) $300.28
- RINVOQ (Biological) $259.94
- ENTYVIO (Biological) $235.97
- IBSRELA (Drug) $186.83
- EXALT MODEL D CONTROLLER (Device) $133.43
- DUPIXENT (Biological) $121.45
- CLENPIQ (Drug) $101.42
- MAVYRET (Drug) $86.27
- LINZESS (Drug) $82.46
- Viekira (Drug) $80.20
- HUMIRA (Biological) $55.90
- GATTEX (Drug) $55.27
- INJECTAFER (Drug) $54.40
- ACQUIRE (Device) $52.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Shreveport
Dr. Sreedhara Alla, M.d, M.D
Internal Medicine — Payments: $637,707
Internal Medicine $637,707
Steven Bailey, Md, MD
Internal Medicine — Payments: $301,538
Internal Medicine $301,538
Prakash Peddi, Md, MD
Internal Medicine — Payments: $277,646
Internal Medicine $277,646
Dr. Maxwell Mcdonald, Md, MD
Internal Medicine — Payments: $192,842
Internal Medicine $192,842
Laurie Grier, M.d, M.D
Internal Medicine — Payments: $69,555
Internal Medicine $69,555
Dr. Rajan Khanna, Md, MD
Internal Medicine — Payments: $66,411
Internal Medicine $66,411